| Characteristic | N = 14 | % |
| Age (year) |
| % |
| Median | 54.5 |
|
| Range | 40.5 - 84 |
|
| Sex |
|
|
| Male | 6 | 42.9 |
| Female | 8 | 57.1 |
| KPS (Karnofsky performance status score) |
|
|
| 100 | 1 | 7.1 |
| 90 | 4 | 28.6 |
| 80 | 4 | 28.6 |
| 70 | 3 | 21.4 |
| 50 | 2 | 14.3 |
| Pancreatic tumor location |
|
|
| Head | 5 | 35.7 |
| Tail | 3 | 21.4 |
| Multicentric (head and body—4, head, body and tail—1, body and tail—1) | 6 | 42.9 |
| Level of CA 19-9 |
|
|
| Normal | 2 | 14.3 |
| Elevated | 12 | 85.7 |
| Metastatic sites in addition to the pancreas |
|
|
| Lymph nodes | 8 | 57.1 |
| Liver | 9 | 64.3 |
| Lungs | 4 | 28.6 |
| Peritoneal | 3 | 21.4 |
| Spleen | 1 | 7.1 |
| Intestine | 1 | 7.1 |
| Ovary | 1 | 7.1 |
| Biliary stent | 6 | 42.9 |
| Whipple procedure | 4 | 28.6 |
| Chemotherapy |
|
|
| 1-line | 7 | 50 |
| 2-line | 5 | 35.7 |
| 3-line and more | 2 | 14.3 |
| Radiation therapy | 2 | 14.3 |